Benzafibrate Dispersible Tablets are often used to treat diseases such as hyperlipidemia and hypercholesterolemia. Benzafibrate is a lipid-regulating drug of clofibric acid derivatives. There are two mechanisms for its lipid-lowering effect, one is that it increases the activity of lipoprotein lipase and hepatic lipase, promotes the decomposition and metabolism of very-low-density lipoprotein, and reduces the level of blood triglyceride. Secondly, the product reduces the secretion of very low density lipoprotein. It is used to treat hypertriglyceridemia, hypercholesterolemia, and mixed hyperlipidemia. The most common adverse effects of this drug are gastrointestinal disturbances such as dyspepsia, anorexia, nausea, vomiting, feeling of fullness, and stomach upset. It is important to note that the use of benzofibrate is prohibited in patients with hepatic insufficiency and renal abnormalities, as well as in pregnant women and children. The use of specific medicines should be combined with their own situation under the guidance of a specialized doctor.